文献速递糖尿病肥胖与代谢综合征

出生体重与近期诊断的2型糖尿病患者的临床特征相关

Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes.
PubMed 文献 · Diabetologia · 2023-06-12

在丹麦DD2队列6866例新诊断2型糖尿病患者中,出生体重每降低1000g与诊断年龄提前3.3年、BMI降低1.5kg/m2及腰围减小3.9cm相关;出生体重<3000g者总体合并症更多、收缩压≥155mmHg的患病率比(PR)为1.26(95%CI 0.99,1.59),且使用≥3种降糖药和≥3种降压药的可能性更高。

要点

  • 出生体重每降低1000g,2型糖尿病诊断年龄提前3.3年(95%CI 2.9,3.8)。
  • 出生体重<3000g者查尔森合并症指数≥3的患病率比(PR)为1.36(95%CI 1.07,1.73)。
  • 出生体重<3000g者使用≥3种降糖药的PR为1.33(95%CI 1.06,1.65)。

核心结论

  • 尽管出生体重<3000g者诊断年龄更轻、肥胖和2型糖尿病家族史比例更低,但其合并症更多(包括收缩压更高),降糖药和降压药使用更多。

研究设计与样本

  • 在丹麦2型糖尿病战略研究中心(DD2)队列中追溯6866例2型糖尿病患者的助产士记录,采用横断面设计。
  • 以出生体重3000-3700g为参照,比较最低25%(<3000g)和最高25%(>3700g)出生体重组,使用对数二项和泊松回归分析。
  • 采用线性和限制性立方样条回归评估整个出生体重谱的连续关系,并计算2型糖尿病和出生体重的加权多基因评分(PS)。

主要发现

  • 出生体重每降低1000g与诊断年龄提前3.3年(95%CI 2.9,3.8)、BMI降低1.5kg/m2(95%CI 1.2,1.7)、腰围减小3.9cm(95%CI 3.3,4.5)相关。
  • 与参照出生体重相比,出生体重<3000g与查尔森合并症指数评分≥3的PR为1.36(95%CI 1.07,1.73)、收缩压≥155mmHg的PR为1.26(95%CI 0.99,1.59)相关。
  • 出生体重<3000g与糖尿病相关神经系统疾病患病率更低、2型糖尿病家族史可能性更低、使用≥3种降糖药的PR为1.33(95%CI 1.06,1.65)、使用≥3种降压药的PR为1.09(95%CI 0.99,1.20)相关。
  • 临床定义的低出生体重(<2500g)关联更强;出生体重与临床特征的大多数关联呈线性,较高出生体重与较低出生体重呈相反方向关联。
  • 结果对代表2型糖尿病和出生体重加权遗传易感性的PS校正稳健。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Low birthweight is a risk factor for type 2 diabetes but it is unknown whether low birthweight is associated with distinct clinical characteristics at disease onset. We examined whether a lower or higher birthweight in type 2 diabetes is associated with clinically relevant characteristics at disease onset. METHODS: Midwife records were traced for 6866 individuals with type 2 diabetes in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort. Using a cross-sectional design, we assessed age at diagnosis, anthropomorphic measures, comorbidities, medications, metabolic variables and family history of type 2 diabetes in individuals with the lowest 25% of birthweight (<3000 g) and highest 25% of birthweight (>3700 g), compared with a birthweight of 3000-3700 g as reference, using log-binomial and Poisson regression. Continuous relationships across the entire birthweight spectrum were assessed with linear and restricted cubic spline regression. Weighted polygenic scores (PS) for type 2 diabetes and birthweight were calculated to assess the impact of genetic predispositions. RESULTS: Each 1000 g decrease in birthweight was associated with a 3.3 year (95% CI 2.9, 3.8) younger age of diabetes onset, 1.5 kg/m2 (95% CI 1.2, 1.7) lower BMI and 3.9 cm (95% CI 3.3, 4.5) smaller waist circumference. Compared with the reference birthweight, a birthweight of <3000 g was associated with more overall comorbidity (prevalence ratio [PR] for Charlson Comorbidity Index Score ≥3 was 1.36 [95% CI 1.07, 1.73]), having a systolic BP ≥155 mmHg (PR 1.26 [95% CI 0.99, 1.59]), lower prevalence of diabetes-associated neurological disease, less likelihood of family history of type 2 diabetes, use of three or more glucose-lowering drugs (PR 1.33 [95% CI 1.06, 1.65]) and use of three or more antihypertensive drugs (PR 1.09 [95% CI 0.99, 1.20]). Clinically defined low birthweight (<2500 g) yielded stronger associations. Most associations between birthweight and clinical characteristics appeared linear, and a higher birthweight was associated with characteristics mirroring lower birthweight in opposite directions. Results were robust to adjustments for PS representing weighted genetic predisposition for type 2 diabetes and birthweight. CONCLUSION/INTERPRETATION: Despite younger age at diagnosis, and fewer individuals with obesity and family history of type 2 diabetes, a birthweight <3000 g was associated with more comorbidities, including a higher systolic BP, as well as with greater use of glucose-lowering and antihypertensive medications, in individuals with recently diagnosed type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Hansen AL, Thomsen RW, Brøns C, et al. Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes. Diabetologia. 2023. PMID: 37303007. doi:10.1007/s00125-023-05936-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。